Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Forensic and Legal Medicine|February 4, 2014
Forensic physicians and written evidence: witness statements v. expert reportsKartina A Choong, Martin BarrettScientific Reports|September 22, 2016
Dampening Spontaneous Activity Improves the Light Sensitivity and Spatial Acuity of Optogenetic Retinal Prosthetic ResponsesJohn Martin Barrett, Gerrit Hilgen, Evelyne SernagorVisual Neuroscience|August 8, 2014
Optogenetic approaches to retinal prosthesisJohn Martin Barrett, Rolando Berlinguer-Palmini, Patrick DegenaarJournal of the Air & Waste Management Association (1995)|October 28, 2017
Evaluation of Chemical Compatibility Testing of Geomembranes Using the Comprehensive Test System and EPA Method 9090William Martin Barrett, Richard Ian Stessel, Frederick A FetterlyPhotosynthesis Research|July 2, 2016
Remembering Joan (Jan) Mary Anderson (1932-2015)Wah Soon Chow, Peter Horton, Martin Barrett, et al.Anesthesia and Analgesia|October 19, 2016
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor: A Biased-Coin Up-and-Down Sequential Allocation Trial to Determine the Optimum Interval Time Between Boluses of a Fixed Volume of 10 mL of Bupivacaine 0.0625% With Fentanyl 2 μg/mLMarcelo Epsztein Kanczuk, Nicholas Martin Barrett, Cristian Arzola, et al.Advances in Therapy|October 7, 2017
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical ExperienceGilles Salles, Martin Barrett, Robin Foà, et al.Journal of Pediatric Surgery|October 16, 2004
Factors influencing early failure of central venous catheters in children with cancerA Martin Barrett, John Imeson, Dawn Leese, et al.Journal of Neural Engineering|August 30, 2018
A head mounted device stimulator for optogenetic retinal prosthesisAhmed Soltan, John Martin Barrett, Pleun Maaskant, et al.The Lancet. Oncology|February 14, 2014
Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 studyAndrew Davies, Francesco Merli, Biljana Mihaljevic, et al.Pageof 2